Prospective analysis of the nutritional status of chemoradiotherapy patients
Royal Darwin Hospital
50 participants
Jul 15, 2013
Observational
Conditions
Summary
The study aims to evaluate the nutritional status of chemo-radiotherapy patients. Who is it for? You may be eligible to join this study if you are aged 18 years or over and are undergoing curative intent chemo-radiotherapy at the Alan Walker Cancer Care Centre in Darwin, Northern Territory. Trial details All participants in this study will have their nutritional status assessed at baseline, first week of treatment, then final week of treatment, and finally at 1-month post treatment using the Patient Generated-Subjective Global Assessment. This is a validated malnutrition assessment tool for cancer patients. This study aims to baseline the nutritional status of chemo-radiotherapy patients undergoing treatment at the Alan Walker Cancer Care Centre (Darwin), identify contributors to nutritional deterioration and determine if there is a difference between Indigenous and non-Indigenous patients. This study will provide a prospective analysis of malnutrition and a clear insight of nutritional status of cancer patients. This study will be the first of its kind to address the nutritional status of cancer patients in Indigenous Australians.
Eligibility
Inclusion Criteria3
- years or over undergoing curative intent chemo-radiotherapy at Alan Walker Cancer Care Centre (AWCCC)
- Able to speak basic English or have an interpreter present
- Able to provide consent
Exclusion Criteria4
- Pregnant or breast feeding women
- Non-English speaking background where interpreter not available
- Change to single modality treatment (i.e. change from chemo-radiotherapy to chemotherapy or radiotherapy alone) or change to treatment intent (i.e. change from curative intent to palliative intent)
- Violent or aggressive patients to maintain the safety of investigators
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
All eligible patients attending the Alan Cancer Care Centre will be consented for participation into this study. Each participant’s nutritional status will be assessed at baseline, first week of treatment, then final week of treatment, and finally at 1-month post treatment using a validated malnutrition assessment tool, the Patient Generated-Subjective Global Assessment. The Patient Generated-Subjective Global Assessment is a validated malnutrition assessment tool for cancer patients.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12613000976785